RSS
Rosenblum Silverman Sutton’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-58,110
| Closed | -$429K | – | 56 |
|
|
2018
Q4 | $429K | Sell |
58,110
-31,390
| -35% | -$232K | 0.2% | 53 |
|
|
2018
Q3 | $1.3M | Buy |
89,500
+15,515
| +21% | +$225K | 0.43% | 48 |
|
|
2018
Q2 | $1.48M | Buy |
73,985
+29,785
| +67% | +$595K | 0.51% | 46 |
|
|
2018
Q1 | $774K | Sell |
44,200
-2,000
| -4% | -$35K | 0.28% | 54 |
|
|
2017
Q4 | $1.14M | Buy |
46,200
+4,600
| +11% | +$113K | 0.41% | 54 |
|
|
2017
Q3 | $1.07M | Buy |
41,600
+3,200
| +8% | +$82.6K | 0.41% | 52 |
|
|
2017
Q2 | $1.04M | Buy |
38,400
+5,650
| +17% | +$153K | 0.42% | 52 |
|
|
2017
Q1 | $977K | Buy |
32,750
+11,600
| +55% | +$346K | 0.41% | 51 |
|
|
2016
Q4 | $574K | Buy |
+21,150
| New | +$574K | 0.27% | 50 |
|